Communiqués Izotropic Corporation

Actions

Marché Fermé - Canadian Securities Exchange Autres places de cotation 19:06:35 02/07/2024			Varia. 5j.	Varia. 1 janv.
0,11 ^CAD	+15,79%		-12,00%	+10,00%

02/04	Izotropic Corporation annonce ses résultats pour le troisième trimestre et les neuf mois clos le 31 janvier 2024	CI
30/01	Izotropic Corporation reçoit une réponse de la FDA américaine	CI

Izotropic Corporation Announces Closing of First Tranche of Non-Brokered Private Placement	14/06	NE
Izotropic Corporation Announces Non-Brokered Private Placement	06/06	NE
Izotropic Receives Response From U.S. FDA	30/01	NE
Izotropic Provides Regulatory and Operational Updates	08/01	NE
Izotropic Provides Regulatory and Operational Updates	08/01	AQ
Izotropic Announces AGM Results	22/12	AQ
Izotropic Completes Pre-Submission Meeting with U.S. FDA	01/11	NE
Izotropic Completes Pre-Submission Meeting With U.S. FDA	01/11	AQ
Izotropic Confirms FDA Pre-Submission Meeting Date	27/09/23	NE
Izotropic Confirms FDA Pre-Submission Meeting Date	27/09/23	AQ
Izotropic Closes Non-Brokered Private Placement	20/09/23	NE
Izotropic Closes Non-Brokered Private Placement	20/09/23	AQ
Izotropic Corporation Announces Non-Brokered Private Placement	13/09/23	AQ
Izotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices	06/09/23	AQ
Izotropic Engages Market Awareness Consultant	27/06/23	AQ
Izotropic Modifies Market Approval Pathway & Strategy	20/06/23	AQ
Izotropic CEO Resigns	08/06/23	AQ
Izotropic Completes QSUB Meeting With FDA Regarding Clinical Study Acceleration	15/05/23	AQ
Izotropic Provides Business Update	27/04/23	AQ
Izotropic to Extend Period for Unsecured Loans	29/03/23	AQ

Aucun résultat pour cette recherche